Cite

HARVARD Citation

    Eskelund, C. et al. (2016). 15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau. British journal of haematology. pp. 410-418. [Online]. 
  
Back to record